Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cra International (CRAI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Cra International (CRAI) over the last 17 years, with Q3 2025 value amounting to $22.5 million.

  • Cra International's Cash & Equivalents fell 810.83% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.5 million, marking a year-over-year decrease of 810.83%. This contributed to the annual value of $26.7 million for FY2024, which is 4140.53% down from last year.
  • Cra International's Cash & Equivalents amounted to $22.5 million in Q3 2025, which was down 810.83% from $19.4 million recorded in Q2 2025.
  • Over the past 5 years, Cra International's Cash & Equivalents peaked at $66.1 million during Q1 2022, and registered a low of $14.0 million during Q3 2021.
  • Over the past 5 years, Cra International's median Cash & Equivalents value was $26.2 million (recorded in 2024), while the average stood at $29.8 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 9995.57% in 2021, then plummeted by 5244.67% in 2022.
  • Cra International's Cash & Equivalents (Quarter) stood at $19.7 million in 2021, then soared by 59.91% to $31.4 million in 2022, then skyrocketed by 44.96% to $45.6 million in 2023, then tumbled by 41.41% to $26.7 million in 2024, then dropped by 15.78% to $22.5 million in 2025.
  • Its Cash & Equivalents stands at $22.5 million for Q3 2025, versus $19.4 million for Q2 2025 and $25.6 million for Q1 2025.